FORZINITY Trademark

Trademark Overview

On Thursday, March 1, 2018, a trademark application was filed for FORZINITY with the United States Patent and Trademark Office. The USPTO has given the FORZINITY trademark a serial number of 87815982. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 25, 2021. This trademark is owned by Stealth Biotherapeutics Corp. The FORZINITY trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical preparations for the prevention and treatment of cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
forzinity

General Information

Serial Number87815982
Word MarkFORZINITY
Filing DateThursday, March 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 25, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements

Goods and ServicesBiopharmaceutical preparations for the prevention and treatment of cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameStealth Biotherapeutics Corp
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMC98000 MC98000
MC
Party NameStealth Biotherapeutics Corp
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMC98000
MC

Trademark Events

Event DateEvent Description
Monday, October 25, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 25, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, February 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2021EXTENSION 5 GRANTED
Tuesday, February 9, 2021EXTENSION 5 FILED
Thursday, February 25, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 9, 2021TEAS EXTENSION RECEIVED
Friday, August 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 26, 2020EXTENSION 4 GRANTED
Wednesday, August 26, 2020EXTENSION 4 FILED
Wednesday, August 26, 2020TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 19, 2020EXTENSION 3 GRANTED
Wednesday, February 19, 2020EXTENSION 3 FILED
Wednesday, February 19, 2020TEAS EXTENSION RECEIVED
Friday, August 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2019EXTENSION 2 GRANTED
Wednesday, August 21, 2019EXTENSION 2 FILED
Wednesday, August 21, 2019TEAS EXTENSION RECEIVED
Friday, February 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2019EXTENSION 1 GRANTED
Wednesday, February 6, 2019EXTENSION 1 FILED
Wednesday, February 6, 2019TEAS EXTENSION RECEIVED
Tuesday, September 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 14, 2018ASSIGNED TO EXAMINER
Thursday, March 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 5, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

forzinity prevention treatment preparations disorders biological abnormalities diseases cellular ophthalmic cardiovascular